Literature DB >> 33394385

Letter to "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?"

Burcu Candemir1, Şafak Akın2.   

Abstract

Entities:  

Year:  2021        PMID： 33394385     DOI： 10.1007/s12020-020-02574-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  2 in total

Review 1.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

Authors:  Shlomo Melmed; Felipe F Casanueva; Andrew R Hoffman; David L Kleinberg; Victor M Montori; Janet A Schlechte; John A H Wass
Journal:  J Clin Endocrinol Metab       Date:  2011-02       Impact factor: 5.958

2.  High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?

Authors:  Etual Espinosa-Cárdenas; Miriam Sánchez-García; Claudia Ramírez-Rentería; Victoria Mendoza-Zubieta; Ernesto Sosa-Eroza; Moises Mercado
Journal:  Endocrine       Date:  2020-06-17       Impact factor: 3.633
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.